Dietary supplementation of fish oils (n-3 PUFA) have been observed to affect insulin action and hence metabolism, affecting the ability to carry out work. Here we examine the effects of fish oil supplementation in conjunction with a glucose load during exertion, on markers of substrate utilization. A pre-test, post-test design was performed on ten healthy young males to assess the effects of 4 weeks fish oil supplementation on muscle metabolism during incremental exertion. Breath-by-breath analysis for respiratory exchange ratio (RER) along with blood lactate and blood glucose were determined at baseline, during exercise following an acute glucose bolus (10% solution at 4 mL/kg/bw), and again following supplementation of 4.2 g.day(-1) (2.2 g EPA, 1.4 g DHA). To examine the effect of fish oil on blood flow, Doppler ultrasound was used to assess femoral blood flow at rest. Following consumption of fish oils, exercising blood glucose and RER were seen to change significantly (4.66±0.44 vs. 4.58±0.31 mmol.L(-1) and 0.97±0.03 vs. 0.99±0.04; p<0.05). Resting femoral arterial blood flow was seen to increase significantly (p<0.05) pre- to post- test; 0.26±0.02-0.30±0.03 L.min(-1). Specific population groups such as those undertaking high-intensity exercise, and clinical groups such as intermittent claudicants, may benefit from the effects of fish oil supplementation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1024/0300-9831/a000189 | DOI Listing |
J Clin Endocrinol Metab
January 2025
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle WA.
Diabetes is associated with increased atherosclerotic cardiovascular disease (ASCVD) risk, a leading cause of morbidity and mortality. Disordered lipid metabolism is a major contributor to ASCVD risk in diabetes. Dyslipidemia in type 2 diabetes is characterized by hypertriglyceridemia, low HDL cholesterol and the presence of small, dense LDL particles.
View Article and Find Full Text PDFNutrients
January 2025
Nutrition and Mental Health (NUTRISAM) Research Group, Universitat Rovira i Virgili, 43201 Reus, Spain.
Background: The balance of omega-6/omega-3 (-6/-3) is crucial for proper brain function as they have opposite physiological roles.
Objectives: To analyze the association between maternal serum ratios of -6/-3 in the first and third trimesters of pregnancy and the neurodevelopment of their children in the early days after birth in the population of Northern Spain's Mediterranean region.
Methods: Longitudinal study in which 336 mother-child pairs participated.
Nutrients
December 2024
Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Pancreatic ductal adenocarcinoma (PDAC) is one of the worst solid malignancies in regard to outcomes and metabolic dysfunction leading to cachexia. It is alarming that PDAC incidence rates continue to increase and warrant the need for innovative approaches to combat this disease. Due to its relatively slow progression (10-20 years), prevention strategies represent an effective means to improve outcomes.
View Article and Find Full Text PDFNutrients
December 2024
Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
Unlabelled: Omega-3 fatty acids (ω-3-FAs) represent a group of essential nutrients, but modern diets often do not allow for a balanced ratio between the intakes of ω-6-FA and ω-3-FA, which is vital for health. ω-3-FA can be found primarily in algae and fish, while the intake of ω-3-FA dietary supplements can be seen as an efficient way of providing nutrients important for many physiological functions.
Background/objectives: The aim of this research was to investigate the use of ω-3-FA-rich food and supplements, as well as the knowledge and attitudes on these nutrients among residents of the central Balkans-the Republic of Serbia and the Republic of Srpska.
Nutrients
December 2024
Department of Experimental and Clinical Medicine, University of Florence, 50134 Firenze, Italy.
Metabolic alterations, including hypermetabolism, lipid imbalances, and glucose dysregulation, are pivotal contributors to the onset and progression of Amyotrophic Lateral Sclerosis (ALS). These changes exacerbate systemic energy deficits, heighten oxidative stress, and fuel neuroinflammation. Simultaneously, gastrointestinal dysfunction and gut microbiota (GM) dysbiosis intensify disease pathology by driving immune dysregulation, compromising the intestinal barrier, and altering gut-brain axis (GBA) signaling, and lastly advancing neurodegeneration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!